Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)Tricia R. Cottrell, Janis M. Taube, Natasha Rekhtman et al.|Annals of Oncology|2018Cited by 588
Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non–Small Cell Lung CancerValsamo Anagnostou, Victor E. Velculescu, Patrick M. Forde et al.|Cancer Research|2018Cited by 313
Inferring gene expression from cell-free DNA fragmentation profilesMohammad Shahrokh Esfahani, Ash A. Alizadeh, Emily G. Hamilton et al.|Nature Biotechnology|2022Cited by 213